Literature DB >> 16083932

RNA interference against enterovirus 71 infection.

Adrian Chong Nyi Sim1, Arthur Luhur, Theresa May Chin Tan, Vincent Tak Kwong Chow, Chit Laa Poh.   

Abstract

Enterovirus 71 (EV71) is a highly infectious major causative agent of hand, foot, and mouth disease (HFMD) which could lead to severe neurological complications. There is currently no effective therapy against EV71. In this study, RNA interference (RNAi) is employed as a therapeutic approach for specific viral inhibition. Various regions of the EV71 genome were targeted for inhibition by chemically synthesized siRNAs. Transfection of rhabdomyosarcoma (RD) cells with siRNA targeting the 3'UTR, 2C, 3C, or 3D region significantly alleviated cytopathic effects of EV71. The inhibitory effect was dosage-dependent with a corresponding decrease in viral RNA, viral proteins, and plaque formations by EV71. Viral inhibition of siRNA transfected RD cells was still evident after 48 h. In addition, no significant adverse off-target silencing effects were observed. These results demonstrated the potential and feasibility for the use of siRNA as an antiviral therapy for EV71 infections.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083932     DOI: 10.1016/j.virol.2005.06.047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus.

Authors:  Jeffrey K Stone; Rene Rijnbrand; David A Stein; Yinghong Ma; Yan Yang; Patrick L Iversen; Raul Andino
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

Review 2.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

3.  Novel multiplex oligonucleotide-conjugated bead suspension array for rapid identification of enterovirus 71 subgenogroups.

Authors:  Y Wu; E L Tan; A Yeo; K P Chan; H Nishimura; M J Cardosa; C L Poh; S H Quak; Vincent T Chow
Journal:  J Clin Microbiol       Date:  2010-11-17       Impact factor: 5.948

4.  Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3.

Authors:  Xiaobo Lei; Zhenmin Sun; Xinlei Liu; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

5.  Enterovirus 71 3C inhibits cytokine expression through cleavage of the TAK1/TAB1/TAB2/TAB3 complex.

Authors:  Xiaobo Lei; Ning Han; Xia Xiao; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

6.  Cleavage of interferon regulatory factor 7 by enterovirus 71 3C suppresses cellular responses.

Authors:  Xiaobo Lei; Xia Xiao; Qinghua Xue; Qi Jin; Bin He; Jianwei Wang
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

7.  Lycorine reduces mortality of human enterovirus 71-infected mice by inhibiting virus replication.

Authors:  Jiangning Liu; Yajun Yang; Yanfeng Xu; Chunmei Ma; Chuan Qin; Lianfeng Zhang
Journal:  Virol J       Date:  2011-10-27       Impact factor: 4.099

8.  The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs.

Authors:  Jun-Xia Deng; Xiao-Jing Nie; Ying-Feng Lei; Chao-Feng Ma; Dong-Liang Xu; Biao Li; Zhi-Kai Xu; Guo-Cheng Zhang
Journal:  J Biomed Sci       Date:  2012-08-13       Impact factor: 8.410

Review 9.  Strategies to develop antivirals against enterovirus 71.

Authors:  Rei-Lin Kuo; Shin-Ru Shih
Journal:  Virol J       Date:  2013-01-22       Impact factor: 4.099

10.  Inhibition of enterovirus 71 (EV-71) infections by a novel antiviral peptide derived from EV-71 capsid protein VP1.

Authors:  Chee Wah Tan; Yoke Fun Chan; Kooi Mow Sim; Eng Lee Tan; Chit Laa Poh
Journal:  PLoS One       Date:  2012-05-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.